Ramachandaram A, Sarvanandan T, Hee NKY, Lim QH, Paramasivam S, Lim LL, et al. REAL-WORLD EVIDENCE FOR THE USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AT A MALAYSIAN TERTIARY CARE CENTRE. J ASEAN Fed Endocr Soc [Internet]. 2023 Nov. 9 [cited 2024 Nov. 22];38(S3):52. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/3325